Literature DB >> 26192489

Mitral valve and papillary muscle abnormalities in hypertrophic obstructive cardiomyopathy.

Eliza P Teo1, Jonathan G Teoh, Judy Hung.   

Abstract

PURPOSE OF REVIEW: This section reviews abnormalities of the mitral valve apparatus that are associated with hypertrophic obstructive cardiomyopathy. RECENT
FINDINGS: Mitral valve abnormalities in hypertrophic obstructive cardiomyopathy include leaflet elongation and thickening and hypertrophy with anterior displacement of the papillary muscles. This combination contributes to the development of systolic anterior motion. The resultant flow forces during systolic anterior motion pulling the leaflets into the left ventricular outflow tract also result in reduced leaflet coaptation and a posteriorly directed mitral regurgitant jet. Additional mitral valve abnormalities include degenerative leaflet changes, aberrant chordal attachments and papillary muscle anomalies.
SUMMARY: Mitral valve abnormalities are common in hypertrophic obstructive cardiomyopathy and play an important role in the pathophysiology of dynamic left ventricular outflow tract obstruction.

Entities:  

Mesh:

Year:  2015        PMID: 26192489     DOI: 10.1097/HCO.0000000000000200

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  7 in total

1.  Does the Flow Know? Mitral Regurgitant Jet Direction and Need for Valve Repair in Hypertrophic Obstructive Cardiomyopathy.

Authors:  Ehud Schwammenthal; Albert A Hagège; Robert A Levine
Journal:  J Am Soc Echocardiogr       Date:  2019-03       Impact factor: 5.251

2.  Outcomes of an extended Morrow procedure without a concomitant mitral valve procedure for hypertrophic obstructive cardiomyopathy.

Authors:  Yun Liu; Yunhu Song; Ge Gao; Jun Ran; Wenjun Su; Haojie Li; Yajie Tang; Fujian Duan; Hansong Sun
Journal:  Sci Rep       Date:  2016-06-30       Impact factor: 4.379

3.  Prognostic significance of anterior mitral valve leaflet length in individuals with a hypertrophic cardiomyopathy gene mutation without hypertrophic changes.

Authors:  Hannah G van Velzen; Arend F L Schinkel; Myrthe E Menting; Annemien E van den Bosch; Michelle Michels
Journal:  J Ultrasound       Date:  2018-06-06

Review 4.  The mechanisms, diagnosis and management of mitral regurgitation in mitral valve prolapse and hypertrophic cardiomyopathy.

Authors:  Mihaela Octavia Popa; Ana Maria Irimia; Mihai Nicolae Papagheorghe; Elena Miruna Vasile; Simona Andreea Tircol; Raluca Andreea Negulescu; Catalina Toader; Robert Adam; Lucian Dorobantu; Cristina Caldararu; Maria Alexandrescu; Sebastian Onciul
Journal:  Discoveries (Craiova)       Date:  2016-06-30

Review 5.  Left Ventricular Hypertrophy: Etiology-Based Therapeutic Options.

Authors:  Begum Yetis Sayin; Ali Oto
Journal:  Cardiol Ther       Date:  2022-03-30

6.  Three-dimensional echocardiography for the assessment of left ventricular geometry and papillary muscle morphology in hypertrophic cardiomyopathy.

Authors:  Mustafa Erden; Hannah G van Velzen; Myrthe E Menting; Annemien E van den Bosch; Ben Ren; Michelle Michels; Wim B Vletter; Ron T van Domburg; Arend F L Schinkel
Journal:  J Ultrasound       Date:  2018-01-06

Review 7.  Comprehensive left ventricular outflow tract management beyond septal reduction to relieve obstruction.

Authors:  Lara Gharibeh; Nicholas G Smedira; Juan B Grau
Journal:  Asian Cardiovasc Thorac Ann       Date:  2021-10-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.